As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the Rules

ConferenceNeutral

AI Analysis

Summary

DIA 2026 Global Annual Meeting scheduled for June 14-18 in Philadelphia will bring together regulators, 20 leading pharmaceutical companies, and over 4,100 drug development professionals to discuss AI's impact on drug development and establish industry guidelines.

Importance:3/10

Sentiment:

0.00

AI in drug developmentConferenceRegulatoryIndustry gathering

Related Companies

$GMRE-PA

Read the original article

Published by PR Newswire Pharma on May 6, 2026 6:11 PM

Read Original